183 related articles for article (PubMed ID: 25128228)
1. Prostate cancer with Paneth cell-like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification.
Park K; Chen Z; MacDonald TY; Siddiqui J; Ye H; Erbersdobler A; Shevchuk MM; Robinson BD; Sanda MG; Chinnaiyan AM; Beltran H; Rubin MA; Mosquera JM
Hum Pathol; 2014 Oct; 45(10):2136-43. PubMed ID: 25128228
[TBL] [Abstract][Full Text] [Related]
2. Concurrent AURKA and MYCN gene amplifications are harbingers of lethal treatment-related neuroendocrine prostate cancer.
Mosquera JM; Beltran H; Park K; MacDonald TY; Robinson BD; Tagawa ST; Perner S; Bismar TA; Erbersdobler A; Dhir R; Nelson JB; Nanus DM; Rubin MA
Neoplasia; 2013 Jan; 15(1):1-10. PubMed ID: 23358695
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate.
Tamas EF; Epstein JI
Am J Surg Pathol; 2006 Aug; 30(8):980-5. PubMed ID: 16861969
[TBL] [Abstract][Full Text] [Related]
4. Variant of prostatic adenocarcinoma with Paneth cell-like neuroendocrine differentiation readily misdiagnosed as Gleason pattern 5.
So JS; Gordetsky J; Epstein JI
Hum Pathol; 2014 Dec; 45(12):2388-93. PubMed ID: 25277321
[TBL] [Abstract][Full Text] [Related]
5. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.
Epstein JI; Amin MB; Beltran H; Lotan TL; Mosquera JM; Reuter VE; Robinson BD; Troncoso P; Rubin MA
Am J Surg Pathol; 2014 Jun; 38(6):756-67. PubMed ID: 24705311
[TBL] [Abstract][Full Text] [Related]
6. Significance of Paneth cell-like differentiation in prostatic adenocarcinoma: a retrospective cohort study of 80 cases.
Salles DC; Mata DA; Epstein JI
Hum Pathol; 2020 Aug; 102():7-12. PubMed ID: 32445653
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
Beltran H; Rickman DS; Park K; Chae SS; Sboner A; MacDonald TY; Wang Y; Sheikh KL; Terry S; Tagawa ST; Dhir R; Nelson JB; de la Taille A; Allory Y; Gerstein MB; Perner S; Pienta KJ; Chinnaiyan AM; Wang Y; Collins CC; Gleave ME; Demichelis F; Nanus DM; Rubin MA
Cancer Discov; 2011 Nov; 1(6):487-95. PubMed ID: 22389870
[TBL] [Abstract][Full Text] [Related]
8. Expression of neuroendocrine differentiation markers in lethal metastatic castration-resistant prostate cancer.
Sainio M; Visakorpi T; Tolonen T; Ilvesaro J; Bova GS
Pathol Res Pract; 2018 Jun; 214(6):848-856. PubMed ID: 29728311
[TBL] [Abstract][Full Text] [Related]
9. Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases.
Adlakha H; Bostwick DG
Hum Pathol; 1994 Feb; 25(2):135-9. PubMed ID: 7509774
[TBL] [Abstract][Full Text] [Related]
10. A case of prostatic adenocarcinoma with Paneth cell-like appearance.
Nakamura Y; Fujishima F; Watanabe M; Taniuchi S; Ishida K; Ishidoya S; Arai Y; Sasano H
Pol J Pathol; 2011; 62(1):60-4. PubMed ID: 21574107
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer with Paneth cell-like neuroendocrine differentiation and extensive perineural invasion: coincidence or causal relationship?
Kakies C; Hakenberg OW; Gunia S; Erbersdobler A
Pathol Res Pract; 2011 Nov; 207(11):715-7. PubMed ID: 21924841
[TBL] [Abstract][Full Text] [Related]
12. Neuroendocrine Differentiation in Metastatic Conventional Prostate Cancer Is Significantly Increased in Lymph Node Metastases Compared to the Primary Tumors.
Genitsch V; Zlobec I; Seiler R; Thalmann GN; Fleischmann A
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28788048
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models.
Sooreshjani MA; Kamra M; Zoubeidi A; Shah K
J Biomed Sci; 2021 Oct; 28(1):68. PubMed ID: 34625072
[TBL] [Abstract][Full Text] [Related]
14. Paneth Cell-Like Component in Prostate Cancer - Case Report.
Šojat J; Jurić B; Šoipi Š; Ulamec M; Krušlin B
Acta Clin Croat; 2018 Oct; 57(Suppl 1):85-88. PubMed ID: 30457254
[TBL] [Abstract][Full Text] [Related]
15. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of the Aurora Kinase A Ile31 allelic variant in human prostate.
Matarasso N; Bar-Shira A; Rozovski U; Rosner S; Orr-Urtreger A
Neoplasia; 2007 Sep; 9(9):707-15. PubMed ID: 17898866
[TBL] [Abstract][Full Text] [Related]
17. Expression of regulators of mitotic fidelity are associated with intercellular heterogeneity and chromosomal instability in primary breast cancer.
Roylance R; Endesfelder D; Jamal-Hanjani M; Burrell RA; Gorman P; Sander J; Murphy N; Birkbak NJ; Hanby AM; Speirs V; Johnston SR; Kschischo M; Swanton C
Breast Cancer Res Treat; 2014 Nov; 148(1):221-9. PubMed ID: 25288231
[TBL] [Abstract][Full Text] [Related]
18. Icaritin suppresses development of neuroendocrine differentiation of prostate cancer through inhibition of IL-6/STAT3 and Aurora kinase A pathways in TRAMP mice.
Sun F; Zhang ZW; Tan EM; Lim ZLR; Li Y; Wang XC; Chua SE; Li J; Cheung E; Yong EL
Carcinogenesis; 2016 Jul; 37(7):701-711. PubMed ID: 27207661
[TBL] [Abstract][Full Text] [Related]
19. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists.
Mohanty SK; Lobo A; Williamson SR; Shah RB; Trpkov K; Varma M; Sirohi D; Aron M; Kandukari SR; Balzer BL; Luthringer DL; Ro J; Osunkoya AO; Desai S; Menon S; Nigam LK; Sardana R; Roy P; Kaushal S; Midha D; Swain M; Ambekar A; Mitra S; Rao V; Soni S; Jain K; Diwaker P; Pattnaik N; Sharma S; Chakrabarti I; Sable M; Jain E; Jain D; Samra S; Vankalakunti M; Mohanty S; Parwani AV; Sancheti S; Kumari N; Jha S; Dixit M; Malik V; Arora S; Munjal G; Gopalan A; Magi-Galluzzi C; Dhillon J
Int J Surg Pathol; 2023 Sep; 31(6):993-1005. PubMed ID: 35946087
[No Abstract] [Full Text] [Related]
20. Paneth cell-like change and small cell carcinoma of the prostate. Two divergent forms of prostatic neuroendocrine differentiation.
Weaver MG; Abdul-Karim FW; Srigley JR
Am J Surg Pathol; 1992 Oct; 16(10):1013-6. PubMed ID: 1329569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
